SARS-CoV-2 pandemic as a model to assess the relationship between intercurrent viral infections and disease activity in Multiple Sclerosis: A propensity score matched case-control study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SARS-CoV-2 pandemic as a model to assess the relationship between intercurrent viral infections and disease activity in Multiple Sclerosis: A propensity score matched case-control study
Authors
Keywords
-
Journal
Multiple Sclerosis and Related Disorders
Volume 74, Issue -, Pages 104715
Publisher
Elsevier BV
Online
2023-04-10
DOI
10.1016/j.msard.2023.104715
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study
- (2022) Masoud Etemadifar et al. BMC Neurology
- Long‐term outcome after COVID ‐19 infection in multiple sclerosis: A nation‐wide multicenter matched‐control study
- (2022) Gabriel Bsteh et al. EUROPEAN JOURNAL OF NEUROLOGY
- COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders
- (2022) Sarah E. Conway et al. Multiple Sclerosis and Related Disorders
- The disease course of multiple sclerosis before and during COVID-19 pandemic: A retrospective five-year study
- (2022) Fawzi Babtain et al. Multiple Sclerosis and Related Disorders
- COVID-19 and the risk of CNS demyelinating diseases: A systematic review
- (2022) Itay Lotan et al. Frontiers in Neurology
- Onset of various CNS inflammatory demyelination diseases following COVID-19 vaccinations
- (2022) Ki Hoon Kim et al. Multiple Sclerosis and Related Disorders
- Association of CNS demyelination and COVID-19 infection: an updated systematic review
- (2021) Ismail Ibrahim Ismail et al. JOURNAL OF NEUROLOGY
- 2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
- (2021) Mike P Wattjes et al. LANCET NEUROLOGY
- Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study
- (2021) Mahdi Barzegar et al. Multiple Sclerosis and Related Disorders
- COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?
- (2021) Masoud Etemadifar et al. Multiple Sclerosis and Related Disorders
- COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies
- (2021) Afagh Garjani et al. Multiple Sclerosis and Related Disorders
- ¿ Can COVID-19 exacerbate multiple sclerosis symptoms? A case series analysis
- (2021) Gloria Michelena et al. Multiple Sclerosis and Related Disorders
- Neurological manifestations of COVID-19, SARS and MERS
- (2020) Kato Verstrepen et al. ACTA NEUROLOGICA BELGICA
- COVID-19 associated with encephalomyeloradiculitis and positive anti-aquaporin-4 antibodies: Cause or coincidence?
- (2020) Diogo Goulart Corrêa et al. Multiple Sclerosis Journal
- Statistical primer: propensity score matching and its alternatives†
- (2018) Umberto Benedetto et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Infection as an Environmental Trigger of Multiple Sclerosis Disease Exacerbation
- (2015) Andrew J. Steelman Frontiers in Immunology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now